| Τύπος | Ημερομηνία | Τίτλος | Δημιουργός | Πλήρες κείμενο |
| 2008 | Sensitivity to TRAIL induced apoptosis in vivo via DR5 receptor up-regulation and the role of oncogenes | Oikonomou, E.; Kosmidou, V.; Katseli, A.; Taoufik, E.; Lesley, P.; Zografos, G.; Andera, L.; Pintzas, Alexander | |
| 2009 | Presence of K-RAS and BRAF oncogenic mutations sensitise colorectal tumours to TRAIL induced apoptosis: evidence from cell and animal models translated to the clinic | Pintzas, Alexander; Oikonomou, E.; Andera, L.; Zografos, G.; Kontogeorgos, G.; Kosmidou, V. | |
| 2009 | TRAIL receptor upregulation and the implication of KRAS/BRAF mutations in human colon cancer tumors | Oikonomou, Eftychia; Kosmidou, Vivian; Katseli, Anastasia; Kothonidis, Konstantinos; Mourtzoukou, Despina; Kontogeorgos, George; Andera, Ladislav; Zografos, Georgios; Pintzas, Alexander | |
| 2010 | RAS and BRAF oncogenes sensitise colorectal tumours to TRAIL induced apoptosis: from cell and animal models to the clinic | Pintzas, Alexander; Oikonomou, E.; Andera, L.; Zografos, G.; Kontogeorgos, G.; Kosmidou, V. | |
| 2011 | Trail induced cell death in colon carcinoma cells in vivo and in vitro: Sensitization by oncogenes and by other therapeutics | Oikonomou, E.; Psahoulia, F.; Kosmidou, V.; Taoufik, E.; Probert, L.; Andera, L.; Pintzas, Alexander | |
| 2013 | EZH2 is regulated by ERK/AKT and targets integrin alpha2 gene to control Epithelial-Mesenchymal Transition and anoikis in colon cancer cells | Ferraro A.; Mourtzoukou D.; Kosmidou V.; Avlonitis S.; Kontogeorgos G.; Zografos G.; Pintzas A. | |
| 2014 | Epigenetic regulation of miR-21 in colorectal cancer: ITGB4 as a novel miR-21 target and a three-gene network (miR-21-ITGB44-PCDC4) as predictor of metastatic tumor potential | Ferraro A.; Kontos C.K.; Boni T.; Bantounas I.; Siakouli D.; Kosmidou V.; Vlassi M.; Spyridakis Y.; Tsipras I.; Zografos G.; Pintzas A. | |
| 2014 | Tumor heterogeneity revealed by KRAS, BRAF, and PIK3CA pyrosequencing: KRAS and PIK3CA intratumor mutation profile differences and their therapeutic implications | Kosmidou V.; Oikonomou E.; Vlassi M.; Avlonitis S.; Katseli A.; Tsipras I.; Mourtzoukou D.; Kontogeorgos G.; Zografos G.; Pintzas A. | |
| 2016 | Death receptor 5 (DR5) and a 5-gene apoptotic biomarker panel with significant differential diagnostic potential in colorectal cancer | Devetzi M.; Kosmidou V.; Vlassi M.; Perysinakis I.; Aggeli C.; Choreftaki T.; Zografos G.N.; Pintzas A. | |
| 2021 | Noxa upregulation and 5-gene apoptotic biomarker panel in colorectal cancer | Kosmidou, Vivian ; Vlassi, Margarita; Anagiotos, Kyriakos; Raftopoulou, Sofia; Kalogerakou, Eirini; Skarmalioraki, Salomi; Aggeli, Chrysanthi; Choreftaki, Theodosia; Zografos, George; Pintzas, Alexander | |
| 2021 | BRAF paradox breakers PLX8394, PLX7904 are more effective against BRAFV600Ε CRC cells compared with the BRAF inhibitor PLX4720 and shown by detailed pathway analysis | Koumaki, Kassandra; Kontogianni, Georgia; Kosmidou, Vivian; Pahitsa, Fani; Kritsi, Eftichia; Zervou, Maria; Chatziioannou, Aristotelis; Souliotis, Vassilis L.; Papadodima, Olga; Pintzas, Alexander | |
| 2023 | Design and Synthesis of Novel 2-Acetamido, 6-Carboxamide Substituted Benzothiazoles as Potential BRAFV600E Inhibitors - In vitro Evaluation of their Antiproliferative Activity | Batsi, Yakinthi; Antonopoulou, Georgia; Fotopoulou, Theano; Koumaki, Kassandra; Kritsi, Eftichia; Potamitis, Constantinos; Goulielmaki, Maria; Skarmalioraki, Salomi; Papalouka, Chara; Poulou-Sidiropoulou, Eleni; Kosmidou, Vivian; Douna, Stavroula; Vidali, Maria-Sofia; Gkotsi, Eleni-Fani; Chatziioannou, Aristotelis; Souliotis, Vassilis L; Pletsa, Vassiliki; Papadodima, Olga; Zoumpourlis, Vassilis; Georgiadis, Panagiotis; Zervou, Maria; Pintzas, Alexander; Kostas, Ioannis D. | |
